474 related articles for article (PubMed ID: 24744600)
1. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
[TBL] [Abstract][Full Text] [Related]
2. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
[TBL] [Abstract][Full Text] [Related]
3. Serum CA724 has no diagnostic value for gastrointestinal tumors.
Cao H; Zhu L; Li L; Wang W; Niu X
Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
[TBL] [Abstract][Full Text] [Related]
4. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
5. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder.
Shukla VK; Gurubachan ; Sharma D; Dixit VK; Usha
Trop Gastroenterol; 2006; 27(4):160-5. PubMed ID: 17542293
[TBL] [Abstract][Full Text] [Related]
7. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
Li F; Li S; Wei L; Liang X; Zhang H; Liu J
Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
[TBL] [Abstract][Full Text] [Related]
8. Exploring the diagnosis markers for gallbladder cancer based on clinical data.
Zhang L; Miao R; Zhang X; Chen W; Zhou Y; Wang R; Zhang R; Pang Q; Xu X; Liu C
Front Med; 2015 Sep; 9(3):350-5. PubMed ID: 26177708
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.
Xu WY; Zhang HH; Yang XB; Bai Y; Lin JZ; Long JY; Xiong JP; Zhang JW; Sang XT; Zhao HT
World J Gastroenterol; 2018 Apr; 24(13):1451-1463. PubMed ID: 29632426
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic role of circulating inflammation-based biomarker in gallbladder carcinoma.
Liu XF; Zhou LY; Wei ZH; Liu JX; Li A; Wang XZ; Ying HQ
Biomark Med; 2018 Oct; 12(10):1095-1103. PubMed ID: 30191731
[TBL] [Abstract][Full Text] [Related]
12. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.
Pang Q; Zhang LQ; Wang RT; Bi JB; Zhang JY; Qu K; Liu SS; Song SD; Xu XS; Wang ZX; Liu C
World J Gastroenterol; 2015 Jun; 21(21):6675-83. PubMed ID: 26074706
[TBL] [Abstract][Full Text] [Related]
13. Application values of detection of serum CA199, CA242 and CA50 in the diagnosis of pancreatic cancer.
Lei XF; Jia SZ; Ye J; Qiao YL; Zhao GM; Li XH; Chang H
J Biol Regul Homeost Agents; 2017; 31(2):383-388. PubMed ID: 28685541
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of CA 242 as a tumor marker in gallbladder cancer.
Rana S; Dutta U; Kochhar R; Rana SV; Gupta R; Pal R; Jain K; Srinivasan R; Nagi B; Nain CK; Singh K
J Gastrointest Cancer; 2012 Jun; 43(2):267-71. PubMed ID: 21573879
[TBL] [Abstract][Full Text] [Related]
15. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
16. Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer.
Su J; Wang Y; Shao H; You X; Li S
World J Surg Oncol; 2022 Sep; 20(1):323. PubMed ID: 36175918
[TBL] [Abstract][Full Text] [Related]
17. Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.
Chen XZ; Zhang WH; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Tumour Biol; 2014 Sep; 35(9):9015-22. PubMed ID: 24906604
[TBL] [Abstract][Full Text] [Related]
18. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer.
Shan D; Cheng S; Ma Y; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1039-1049. PubMed ID: 37724407
[TBL] [Abstract][Full Text] [Related]
20. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
Tong Y; Zhao Y; Shan Z; Zhang J
BMC Cancer; 2021 Jan; 21(1):4. PubMed ID: 33402124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]